Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma

(2010) K. T. Kuo et al.   CLINICAL CANCER RESEARCH

The Role of Hepatocyte Nuclear Factor-1β in the Pathogenesis of Clear Cell Carcinoma of the Ovary

(2010) Hiroshi Kobayashi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma

(2010) Daichi Maeda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary

(2009) Emanuela Veras et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

(2009) Martin Köbel et al.   MODERN PATHOLOGY

The SWI/SNF complex and cancer

(2009) D Reisman et al.   ONCOGENE